Blogs & Articles

Stay ahead of evolving healthcare engagement strategies with Neolytic’s blog. Insights on expert engagement, digital sentiment, and influence networks, designed to help life sciences teams move from data to decisive action.
In the dynamic and ever-evolving pharmaceutical landscape, the role of Medical Affairs is becoming increasingly pivotal. Medical Affairs serves as the essential bridge between the scientific community and the commercial sector, ensuring that cutting-edge research
Sentiment analysis analyzes your KOL’s sentiments towards products, companies, brands and focus areas to understand whether these opinions are positive, negative, or neutral. Sentiment analysis helps pharma companies to engage with KOLs.
Launching a biopharma product is a complex process. The effectiveness of multiple factors, such as a strong pre-launch medical strategy, the role of key healthcare professionals, strategic resource allocation, and launch targeting strategy, often defines
Badal Shah, visionary Founder and President of Neolytica, has been named the 2023-2024 Global Indian of the Year in Healthcare. This prestigious award recognizes Badal’s expertise that has contributed to cutting-edge technologies like Generative AI,
MORRISTOWN, N.J – QPharma, a compliance and commercial services leader in the life sciences industry, is thrilled to announce Mr. Badal Shah, B.Pharm, M.B.S, as President of Neolytica, its healthcare analytics division.
In the ever-evolving landscape of the BioPharma industry, the need for innovative approaches has become more pressing than ever. As traditional marketing channels lose their effect, the industry embraces unconventional methods to identify Key Opinion
In the dynamic landscape of the biopharma industry, where innovation and clinical expertise must converge, it’s not just the well-known figures that make a significant impact. While the superstars often grab the spotlight, there’s an
In the ever-evolving landscape of the pharmaceutical industry, market access has become a critical factor in the success of new therapies and products. Gaining reimbursement and securing formulary positioning are essential for ensuring patient access
In the fiercely competitive pharmaceutical industry, an effective influence strategy is paramount for achieving market access and commercial success. Regional key decision makers, such as formulary committees, reimbursement authorities, and healthcare administrators, hold significant sway
Relationships are the key to success, and building a strong network of advisors can be the difference between a stagnant business and one that thrives. In this case study, we’ll explore the Orbital Theory of
In today’s dynamic healthcare landscape, relying solely on syndicated Key Opinion Leader (KOL) databases is no longer sufficient for pharmaceutical companies aiming to establish themselves as industry leaders. As disease management evolves and personalized treatment
Due to the rapidly changing landscape of the pharmaceutical industry, maximizing influence within the market remains of utmost importance. Both Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) serve as surrogates of information to
Scroll to Top

Get in Touch